Resource Library

We developed this site to be a repository of educational information about recurrent pericarditis for US healthcare providers. The resource library includes publications, slide programs, and educational images to support you in understanding and managing recurrent pericarditis in your practice.

Educational Slide Presentations

The Burden of Recurrent Pericarditis

Current challenges in disease management


This slide deck provides information on the disease, differences between a first episode and recurrent pericarditis, and recent shifts in the treatment paradigm



The Pathophysiology of Recurrent Pericarditis

3D animated video

Watch Video

Pathophysiology Images

The Self-Perpetuating Cycle of IL-1–Mediated Autoinflammation in Recurrent Pericarditis

Flat schematic, in color, of the cycle of autoinflammation that drives recurrent pericarditis


References and Citations

The following references were used in the creation of this web content. Click the
button next to the citation to gain access to each article, poster, or website.

Anti-Interleukin-1 Agents for Pericarditis: A Primer for Cardiologists.

Imazio M, Lazaros G, Gattorno M, et al. Eur Heart J. 2022;43(31):2946-2957. doi:10.1093/eurheartj/ehab452

New Developments in The Management of Recurrent Pericarditis.

Imazio M, Mardigyan V, Andreis A, Franchin L, De Biasio M, Collini V. Can J Cardiol. 2023;17:S0828-282X(23)00309-4. doi:10.1016/j.cjca.2023.04.008

Clinical Burden and Unmet Need in Recurrent Pericarditis: A Systematic Literature Review.

Klein A, Cremer P, Kontzias A, et al. Cardiol Rev. 2022;30(2):59-69. doi:10.1097/CRD.0000000000000356

US Database Study of Clinical Burden and Unmet Need in Recurrent Pericarditis.

Klein A, Cremer P, Kontzias A, et al. J Am Heart Assoc. 2021;10:e018950. doi:10.1161/JAHA.120.018950

Advances in Imaging and Targeted Therapies for Recurrent Pericarditis.

Kumar S, Khubber S, Reyaldeen R, et al. JAMA Cardiol. 2022;7(9):975. doi:10.1001/jamacardio.2022.2584

Quantitative Assessment of Pericardial Delayed Hyperenhancement Helps Identify Patients With Ongoing Recurrences of Pericarditis.

Kumar A, Sato K, Verma BR, et al. Open Heart. 2018;5(2):e000944. doi:10.1136/openhrt-2018-000944

Burden of Recurrent Pericarditis on Health-Related Quality of Life.

LeWinter M, Kontzias A, Lin D, et al. Am J Cardiol. 2021;141:113-119. doi:10.1016/j.amjcard.2020.11.018

Disease and Economic Burden Associated With Recurrent Pericarditis in a Privately Insured United States Population.

Lin D, Laliberté F, Majeski C, et al. Adv Ther. 2021;38(10):5127-5143. doi:10.1007/s12325-021-01868-7

Estimating the US Pericarditis Prevalence Using National Health Encounter Surveillance Databases.

Luis SA, LeWinter MM, Magestro M, et al. Curr Med Res Opin. 2022;38(8):1385-1389. doi:10.1080/03007995.2022.2070381.

The Role of NLRP3 Inflammasome in Pericarditis: Potential for Therapeutic Approaches.

Mauro AG, Bonaventura A, Vecchié A, et al. JACC Basic Transl Sci. 2021;6(2):137-150. doi:10.1016/j.jacbts.2020.11.016

Advances in Pharmacotherapy for Acute and Recurrent Pericarditis.

Vecchié A, Del Buono MG, Mauro AG, et al. Expert Opin Pharmacother. 2002;23(6):681-691. doi:10.1080/14656566.2022.2054327